AAAAAA
Results:
1-20
|
Results: 20
Authors:
Duong, M
Petit, JM
Piroth, L
Grappin, M
Buisson, M
Chavanet, P
Hillon, S
Portier, H
Citation: M. Duong et al., Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy, J ACQ IMM D, 27(3), 2001, pp. 245-250
Authors:
Guezennec, CY
Louisy, F
Portier, H
Laude, D
Chapuis, B
Plesant, J
Citation: Cy. Guezennec et al., Effects of aerobatics flight on oxygen consumption and heart rate control:influence on autonomic cardiovascular regulation during recovery, EUR J A PHY, 84(6), 2001, pp. 562-568
Authors:
Duong, M
Piroth, L
Peytavin, G
Forte, F
Kohli, E
Grappin, M
Buisson, M
Chavanet, P
Portier, H
Citation: M. Duong et al., Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response, CLIN INF D, 33(3), 2001, pp. 386-392
Authors:
Portier, H
Bourrillon, A
Lucht, F
Choutet, P
Gehanno, P
Meziane, L
Bingen, E
Citation: H. Portier et al., Evaluation of short course of josamycin in children with group A streptococcal tonsillitis, ARCH PED, 8(7), 2001, pp. 700-706
Authors:
Portier, H
Peyramond, D
Boucot, I
Pribil, C
Grappin, M
Chicoye, A
Citation: H. Portier et al., Pharmaco-economic evaluation of the use of rapid diagnostic test of adult angina, MED MAL INF, 31(7-8), 2001, pp. 506-507
Authors:
Weber, P
Filipecki, J
Bingen, E
Fitoussi, F
Goldfarb, G
Chauvin, JP
Reitz, C
Portier, H
Citation: P. Weber et al., Genetic and phenotypic characterization of macrolide resistance in group Astreptococci isolated from adults with pharyngo-tonsillitis in France, J ANTIMICRO, 48(2), 2001, pp. 291-294
Authors:
Piroth, L
Desbiolles, N
Mateo-Ponce, V
Martin, L
Lequeu, C
Charles, PE
Portier, H
Chavanet, P
Citation: L. Piroth et al., HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae, J ANTIMICRO, 47(1), 2001, pp. 33-42
Authors:
Portier, H
Louisy, F
Laude, D
Berthelot, M
Guezennec, CY
Citation: H. Portier et al., Intense endurance training on heart rate and blood pressure variability inrunners, MED SCI SPT, 33(7), 2001, pp. 1120-1125
Authors:
Duong, M
Buisson, M
Cottin, Y
Piroth, L
Lhuillier, I
Grappin, M
Chavanet, P
Wolff, JE
Portier, H
Citation: M. Duong et al., Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review, CLIN CARD, 24(10), 2001, pp. 690-694
Authors:
Desbiolles, N
Piroth, L
Lequeu, C
Neuwirth, C
Portier, H
Chavanet, P
Citation: N. Desbiolles et al., Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcusfaecalis and penicillin-resistant Streptococcus pneumoniae, ANTIM AG CH, 45(12), 2001, pp. 3328-3333
Authors:
Piroth, L
Grappin, M
Petit, JM
Buisson, M
Duong, M
Chavanet, P
Portier, H
Citation: L. Piroth et al., Incidence of gynecomastia in men infected with HIV and treated with highlyactive antiretroviral therapy, SC J IN DIS, 33(7), 2001, pp. 559-560
Authors:
Grappin, M
Piroth, L
Kohli, E
Buisson, M
Duong, M
Chavanet, P
Portier, H
Citation: M. Grappin et al., Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice, J ACQ IMM D, 25(5), 2000, pp. 464-465
Authors:
Piroth, L
Grappin, M
Buisson, M
Duong, M
Portier, H
Chavanet, P
Citation: L. Piroth et al., Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy, J ACQ IMM D, 23(4), 2000, pp. 356-357
Authors:
Piroth, L
Grappin, M
Cuzin, L
Mouton, Y
Bouchard, O
Raffi, F
Rey, D
Peyramond, D
Gourdon, F
Drobacheff, C
Lombart, ML
Lucht, F
Besnier, JM
Bernard, L
Chavanet, P
Portier, H
Citation: L. Piroth et al., Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients, J VIRAL HEP, 7(4), 2000, pp. 302-308
Authors:
Piednoir, E
Muggeo, E
Chavanet, P
Talpin, V
Aho, LS
Portier, H
Citation: E. Piednoir et al., Quality of care when dealing with a multiresistant bacteria infection in the Dijon university hospital., MED MAL INF, 30(2), 2000, pp. 87-93
Authors:
Grappin, M
Piroth, L
Verges, B
Sgro, C
Mack, G
Buisson, M
Duong, M
Chavanet, P
Portier, H
Citation: M. Grappin et al., Increased prevalence of subclinical hypothyroidism in HIV patients treatedwith highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1070-1072
Authors:
Petit, JM
Duong, M
Duvillard, L
Piroth, L
Grappin, M
Verges, B
Chavanet, P
Brun, JM
Portier, H
Citation: Jm. Petit et al., HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: A longitudinal study, HORMONE MET, 32(9), 2000, pp. 367-372
Authors:
Piroth, L
Grappin, M
Waldner, A
Sgro, C
Duong, M
Buisson, M
Chavanet, P
Portier, H
Citation: L. Piroth et al., Discontinuation of protease inhibitors due to intolerance: a longitudinal study in 309 HIV-1 positive patients, PRESSE MED, 28(8), 1999, pp. 381-387
Authors:
Piroth, L
Bourgeois, C
Dantin, S
Waldner, A
Grappin, M
Portier, H
Chavanet, P
Citation: L. Piroth et al., Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients, AIDS, 13(4), 1999, pp. 523-524
Authors:
Piroth, L
Martin, L
Coulon, A
Lequeu, C
Duong, M
Buisson, M
Portier, H
Chavanet, P
Citation: L. Piroth et al., Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics, ANTIM AG CH, 43(10), 1999, pp. 2484-2492
Risultati:
1-20
|